DNA Synthesis Market Size

DNA Synthesis Market size was valued at USD 3.46 Billion in 2023 and is poised to grow from USD 4.14 Billion in 2024 to USD 17.38 Billion by 2032, growing at a CAGR of 19.63% during the forecast period (2025-2032).

The competitive landscape of the DNA synthesis market is characterized by a diverse array of companies offering a range of synthesis services and technologies. These companies compete based on factors such as the quality and accuracy of synthesized DNA, turnaround times, customization options, and pricing. 'Thermo Fisher Scientific, Inc. (US)', 'Twist Bioscience (US)', 'Bioneer Corporation (South Korea)', 'Eton Bioscience (US)', 'LGC Biosearch Technologies (US)', 'IBA GmbH (Germany)', 'Eurofins Scientific (Luxembourg)', 'Integrated DNA Technologies, Inc. (US)', 'Quintara Biosciences (US)', 'GenScript Biotech Corporation (China)', 'Agilent Technologies (US)', 'Merck KGaA (Germany)', 'Eurogentec (Belgium)', 'Cambio Ltd. (UK)', 'Biomatik (Canada)'

A major key market driver for the DNA synthesis market is the continuous advancements in genetic engineering technologies. These innovations, including CRISPR-Cas9 and other gene-editing techniques, have significantly increased the demand for custom DNA sequences, driving the growth of DNA synthesis services. Researchers and biotech companies require precise and tailored DNA constructs for their experiments and applications, making DNA synthesis a critical component of cutting-edge genetic engineering projects.

Advancements in Gene Editing Technologies: A major market trend in the DNA synthesis industry is the continuous advancement of gene editing technologies, such as CRISPR-Cas9. These technologies are driving demand for custom DNA sequences, as they enable precise genetic modifications for a wide range of applications, including therapeutic development and agriculture. As gene editing tools become more accessible and versatile, the DNA synthesis market is poised for sustained growth, catering to the evolving needs of researchers and biotech companies.

North America is currently the dominating region in the global DNA synthesis market. This dominance can be attributed to the presence of well-established biotechnology and pharmaceutical industries, strong research and development capabilities, and a higher adoption rate of advanced biotechnological tools and techniques. Additionally, favorable regulatory environments and significant investments in genomics research contribute to North America's leadership in this market.